- Home
- BWMX vs HUMA Comparison
BWMX vs HUMA Comparison
Compare BWMX & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWMX
- HUMA
- Stock Information
- Founded
- BWMX 1995
- HUMA 2004
- Country
- BWMX Mexico
- HUMA United States
- Employees
- BWMX N/A
- HUMA N/A
- Industry
- BWMX Catalog/Specialty Distribution
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- BWMX Consumer Discretionary
- HUMA Health Care
- Exchange
- BWMX Nasdaq
- HUMA Nasdaq
- Market Cap
- BWMX 447.8M
- HUMA 427.2M
- IPO Year
- BWMX N/A
- HUMA N/A
- Fundamental
- Price
- BWMX $11.40
- HUMA $1.43
- Analyst Decision
- BWMX Strong Buy
- HUMA Strong Buy
- Analyst Count
- BWMX 1
- HUMA 6
- Target Price
- BWMX $22.50
- HUMA $14.60
- AVG Volume (30 Days)
- BWMX 16.3K
- HUMA 4.0M
- Earning Date
- BWMX 04-24-2025
- HUMA 03-28-2025
- Dividend Yield
- BWMX 12.10%
- HUMA N/A
- EPS Growth
- BWMX N/A
- HUMA N/A
- EPS
- BWMX 0.92
- HUMA N/A
- Revenue
- BWMX $676,704,288.00
- HUMA N/A
- Revenue This Year
- BWMX $8.79
- HUMA N/A
- Revenue Next Year
- BWMX $6.14
- HUMA $1,217.58
- P/E Ratio
- BWMX $12.42
- HUMA N/A
- Revenue Growth
- BWMX 8.39
- HUMA N/A
- 52 Week Low
- BWMX $10.05
- HUMA $1.70
- 52 Week High
- BWMX $20.36
- HUMA $9.97
- Technical
- Relative Strength Index (RSI)
- BWMX 48.91
- HUMA 24.32
- Support Level
- BWMX $11.47
- HUMA $1.96
- Resistance Level
- BWMX $12.00
- HUMA $3.36
- Average True Range (ATR)
- BWMX 0.42
- HUMA 0.24
- MACD
- BWMX 0.01
- HUMA -0.11
- Stochastic Oscillator
- BWMX 32.25
- HUMA 0.30
About BWMX Betterware de Mexico S.A.P.I. de C.V.
Betterware de Mexico SAPI de CV is a direct-to-consumer selling company. The company operates through two business segments: the home organization products (Betterware segment or BWM segment) and the beauty and personal care products (B and PC) (JAFRA segment). The Betterware's segment is divided into different categories based on the type of products it sells and includes, kitchen and food preservation, home solutions, bathroom, laundry & cleaning, tech and mobility, and bedroom and wellness products. The JAFRA's segment is divided into fragrance, color, skincare, and toiletries products. The company generates a majority of its revenue from the Beauty and personal care (B&PC) (JAFRA segment). Geographically, key revenue for the company is derived from Mexico.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.